Jeffrey Dierks, Chief Commercial Officer at Harmony Biosciences Holdings, Inc. (HRMY), sold 20,000 shares at $41.36 ($834K) on 2021-11-01, disclosed to the SEC on 2021-11-03.
Open-market sale of $834k HRMY by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.36 | 7,054 | $292K | 35.0% |
| 2 | $41.36 | 7,054 | $292K | 35.0% |
| 3 | $42.44 | 2,946 | $125K | 15.0% |
| 4 | $42.44 | 2,946 | $125K | 15.0% |
| Total | $41.68 avg | 20,000 | $834K | 100% |
| Filing → |
| HRMY | SELL | 2025-01-21 | $2.3M | — | Filing → |
| HRMY | SELL | 2025-01-16 | $778K | — | Filing → |
| HRMY | SELL | 2025-01-15 | $532K | — | Filing → |